The FDA has granted Respicardia, a company out of Minnetonka, Minnesota, approval to introduce its Remedē implantable sleep apnea treatment system. The Remedē treats sleep apnea by stimulating one of the phrenic nerves that regulates the activity of the diaphragm. People with central sleep apnea exhibit shallow breaths and/or pauses in breathing t (Read more...)